Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. [electronic resource]
- Bone Nov 2014
- 146-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2763
10.1016/j.bone.2014.08.018 doi
Animals Animals, Newborn Bone Development--drug effects Bone Neoplasms--drug therapy Child Craniofacial Abnormalities--chemically induced Diphosphonates--therapeutic use Female Humans Imidazoles--therapeutic use Mice, Inbred C57BL Phenotype Tibia--diagnostic imaging X-Ray Microtomography Zoledronic Acid